Russia’s $6 billion pharmaceutical programme Pharma2020, which aims to develop the country’s healthcare and pharmaceutical industry through supporting local drug manufacturers, would like to increase the share of domestically produced drugs to 50 percent by 2020 from 20 percent in 2007. For Indian drug manufacturers and exporters, the time has come to follow the strategy…